Crystal-af trial
WebThe trial also found that for cetuximab to be active, an unmutated KRAS gene i... This trial shows activity of the combination of fluorouracil-based chemotherapy and cetuximab as … WebMar 31, 2024 · We modeled the economic impact of anticoagulating ESUS patients without documented AF across multiple geographies. Methods: CRYSTAL-AF trial data were used to assess ischaemic stroke event rates in ESUS patients confirmed AF …
Crystal-af trial
Did you know?
WebJun 19, 2009 · When a stroke patient is found to have atrial fibrillation (AF), the guidelines recommend oral anticoagulation due to its superior efficacy over aspirin for stroke … WebJan 7, 2024 · In the CRYSTAL AF trial, the median time for atrial fibrillation (AF) detection via implanted cardiac monitor (ICM) was 8.4 months. A meta-analysis of ICM use in patients monitored for AF reported detection rates of 5% for <6 months, 26% for 12-24 months, and 34% for >24 months of monitoring.
WebThe AF detection rate in our cohort was compared to the rate in CRYSTAL-AF Trial at 36-month follow-up. The impact of AF detection on clinical management was examined. Results: We identified 225 patients. 51.1% were women and 38.2% African American. Among 85 patients with ILR labeled AF, 43 patients had true AF, and 42 had incorrectly labeled ... WebIn this investigator-initiated, open-label, multicenter trial, we randomly assigned participants in a 1:1 ratio to undergo ambulatory ECG monitoring with a 30-day event-triggered loop …
WebDec 6, 2024 · Patients were randomly assigned 1:1 to 5 mg of apixaban twice daily (2.5 mg twice daily for patients ≥80 years of age, weight ≤60 kg, or both) or dose-adjusted warfarin. The primary outcome was time to major or clinically relevant nonmajor bleeding. Secondary outcomes included stroke, mortality, and apixaban pharmacokinetics. WebJun 26, 2014 · Collaborators. CRYSTAL AF Investigators : Tommaso Sanna , Hans-Christoph Diener , Rod S Passman , Vincenzo Di Lazzaro , Richard A Bernstein , Carlos A Morillo , …
WebApr 11, 2024 · The CRYSTAL AF trial design has been described in detail elsewhere. 3, 12 The study protocol was approved by all relevant institutional review boards or ethics committees, and all patients provided written informed consent before randomization. The trial is registered under CRYSTAL AF (ClinicalTrials.gov identifier: NCT00924638).
WebFeb 22, 2016 · The Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT) was designed to … try gpt-4WebMar 8, 2024 · The trial was approved by the ethics committee at each participating site, and all patients provided written consent. The trial was funded by the National Institute of … try gpt 4WebIn CRYSTAL-AF, moreover, the stroke rate at 1 year was lower in participants randomly assigned to the implantable cardiac monitor (ICM) arm compared with those assigned to conventional monitoring (7.1% vs 9.1%, P >.05), although the … philip zaneteas mdWebFeb 15, 2014 · CRYSTAL-AF: Monitor Detects AF in Cryptogenic Stroke Sue Hughes February 15, 2014 An implanted cardiac monitor was much more effective at picking up … try gpt4WebNov 7, 2024 · The association between atrial fibrillation (AF) and stroke can be conceptualized by 2 models: AF as a risk marker or AF as a direct cause of stroke. These … philip zachrissonWebOct 2, 2014 · The Cryptogenic Stroke and Underlying AF (CRYSTAL AF) trial [] is a prospective, multicenter randomized controlled trial conducted between June 2009 and April 2012, aimed at assessing whether long-term monitoring with an implanted cardiac monitor (ICM) is more effective than conventional follow-up for detecting episodes of AF after … philip youtieWebSep 9, 2014 · In the CRYSTAL AF trial, by the sixth month, new AF was detected in 8.9% of patients with implantable cardiac monitor when compared with 1.4% among those … philip zec poster factory